Clinical Research Directory
Browse clinical research sites, groups, and studies.
Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma
Sponsor: Guangxi Medical University
Summary
This multicenter retrospective study which included patients with hepatocellular carcinoma (HCC) who received conversion or neoadjuvant therapy to explore the best treatment options and the best benefit group.
Official title: Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma: A Multicenter Retrospective Study in Guangxi, China (GUIDANCE)
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2019-01-01
Completion Date
2026-12-31
Last Updated
2026-01-14
Healthy Volunteers
No
Conditions
Interventions
Conversion or neoadjuvant therapy.
Patients with hepatocellular carcinoma received conversion or neoadjuvant therapy.
Locations (1)
Jian-Hong Zhong
Nanning, China, China